![Chemistry / Gilead Sciences / Medicine / Clinical medicine / Cyclopropanes / Breakthrough therapy / Combination drugs / Organofluorides / Sofosbuvir / Ledipasvir / Simeprevir / Velpatasvir/sofosbuvir Chemistry / Gilead Sciences / Medicine / Clinical medicine / Cyclopropanes / Breakthrough therapy / Combination drugs / Organofluorides / Sofosbuvir / Ledipasvir / Simeprevir / Velpatasvir/sofosbuvir](https://www.pdfsearch.io/img/763cd55ea5b173975689fd1ecab036b6.jpg) Date: 2016-06-28 12:26:37Chemistry Gilead Sciences Medicine Clinical medicine Cyclopropanes Breakthrough therapy Combination drugs Organofluorides Sofosbuvir Ledipasvir Simeprevir Velpatasvir/sofosbuvir | | --------------------------------CONTRAINDICATIONS----------------------------- EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBINAdd to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source Website File Size: 872,45 KBShare Document on Facebook
|